227 related articles for article (PubMed ID: 34130007)
1. Saliva based non invasive screening of Oral Submucous Fibrosis using ATR-FTIR spectroscopy.
Shaikh S; Yadav DK; Rawal R
J Pharm Biomed Anal; 2021 Sep; 203():114202. PubMed ID: 34130007
[TBL] [Abstract][Full Text] [Related]
2. Serum-based diagnostic prediction of oral submucous fibrosis using FTIR spectrometry.
Rai V; Mukherjee R; Routray A; Ghosh AK; Roy S; Ghosh BP; Mandal PB; Bose S; Chakraborty C
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jan; 189():322-329. PubMed ID: 28826108
[TBL] [Abstract][Full Text] [Related]
3. Spectrochemical differentiation of meningioma tumours based on attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy.
Lilo T; Morais CLM; Ashton KM; Pardilho A; Davis C; Dawson TP; Gurusinghe N; Martin FL
Anal Bioanal Chem; 2020 Feb; 412(5):1077-1086. PubMed ID: 31865413
[TBL] [Abstract][Full Text] [Related]
4. Differential Molecular Signature of Human Saliva Using ATR-FTIR Spectroscopy for Chronic Kidney Disease Diagnosis.
Rodrigues RP; Aguiar EM; Cardoso-Sousa L; Caixeta DC; Guedes CC; Siqueira WL; Maia YCP; Cardoso SV; Sabino-Silva R
Braz Dent J; 2019; 30(5):437-445. PubMed ID: 31596327
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Measurement of Salivary Urea by ATR-FTIR Spectroscopy to Screen for CKD.
Lin TL; Evans RDR; Unwin RJ; Norman JT; Rich PR
Kidney360; 2022 Feb; 3(2):357-363. PubMed ID: 35373139
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of dyslipidemia types with ATR-FTIR spectroscopy and chemometrics associated with multivariate analysis of the lipid profile, anthropometric, and pro-inflammatory biomarkers.
de Souza NMP; Machado BH; Koche A; da Silva Furtado LBF; Becker D; Corbellini VA; Rieger A
Clin Chim Acta; 2023 Feb; 540():117231. PubMed ID: 36682440
[TBL] [Abstract][Full Text] [Related]
7. Rapid intraoperative diagnosis of gynecological cancer by ATR-FTIR spectroscopy of fresh tissue biopsy.
Malonek D; Dekel BZ; Haran G; Reens-Carmel R; Groisman GM; Hallak M; Bruchim I
J Biophotonics; 2020 Sep; 13(9):e202000114. PubMed ID: 32463546
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Analysis of Saliva for Breast Cancer Diagnosis.
Ferreira ICC; Aguiar EMG; Silva ATF; Santos LLD; Cardoso-Sousa L; Araújo TG; Santos DW; Goulart LR; Sabino-Silva R; Maia YCP
J Oncol; 2020; 2020():4343590. PubMed ID: 32104176
[TBL] [Abstract][Full Text] [Related]
9. Fast screening using attenuated total reflectance- fourier transform infrared (ATR-FTIR) spectroscopy of patients based on D-dimer threshold value.
Brun BF; Nascimento MHC; Dias PAC; Marcarini WD; Singh MN; Filgueiras PR; Vassallo PF; Romão W; Mill JG; Martin FL; Barauna VG
Talanta; 2024 Mar; 269():125482. PubMed ID: 38042146
[TBL] [Abstract][Full Text] [Related]
10. Identification of myocardial fibrosis by ATR-FTIR spectroscopy combined with chemometrics.
Yang X; Wei X; Yu K; Wan C; Wang Y; Huang S; Sun Q; Huang J
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 264():120238. PubMed ID: 34384995
[TBL] [Abstract][Full Text] [Related]
11. ATR-FTIR spectroscopy coupled with chemometric analysis discriminates normal, borderline and malignant ovarian tissue: classifying subtypes of human cancer.
Theophilou G; Lima KM; Martin-Hirsch PL; Stringfellow HF; Martin FL
Analyst; 2016 Jan; 141(2):585-94. PubMed ID: 26090781
[TBL] [Abstract][Full Text] [Related]
12. A biospectroscopic approach toward colorectal cancer diagnosis from bodily fluid samples via ATR-MIR spectroscopy combined with multivariate data analysis.
Tugrul F; Akin Geyik G; Yalinbaş Kaya B; Peker Cengiz B; Karuk Elmas SN; Yilmaz I; Arslan FN
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jan; 304():123342. PubMed ID: 37688884
[TBL] [Abstract][Full Text] [Related]
13. Attenuated total reflection Fourier-transform infrared spectral discrimination in human bodily fluids of oesophageal transformation to adenocarcinoma.
Maitra I; Morais CLM; Lima KMG; Ashton KM; Date RS; Martin FL
Analyst; 2019 Dec; 144(24):7447-7456. PubMed ID: 31696873
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
15. ATR-FTIR spectroscopy and chemometrics: An interesting tool to discriminate and characterize counterfeit medicines.
Custers D; Cauwenbergh T; Bothy JL; Courselle P; De Beer JO; Apers S; Deconinck E
J Pharm Biomed Anal; 2015 Aug; 112():181-9. PubMed ID: 25476739
[TBL] [Abstract][Full Text] [Related]
16. Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Discriminates the Elderly with a Low and High Percentage of Pathogenic CD4+ T Cells.
Praja RK; Wongwattanakul M; Tippayawat P; Phoksawat W; Jumnainsong A; Sornkayasit K; Leelayuwat C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159268
[TBL] [Abstract][Full Text] [Related]
17. Detection and discrimination of sedative-hypnotics in spiked beverage dry residues using attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy combined with chemometrics.
Teoh WK; Mohamed Sadiq NS; Saisahas K; Phonchai A; Kunalan V; Md Muslim NZ; Limbut W; Abdullah AFL; Chang KH
J Forensic Sci; 2023 Jan; 68(1):75-85. PubMed ID: 36273275
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
19. Development of a non-destructive methodology using ATR-FTIR and chemometrics to discriminate wild silk species in heritage collections.
de Palaminy L; Daher C; Moulherat C
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Apr; 270():120788. PubMed ID: 34990920
[TBL] [Abstract][Full Text] [Related]
20. FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer.
Zlotogorski-Hurvitz A; Dekel BZ; Malonek D; Yahalom R; Vered M
J Cancer Res Clin Oncol; 2019 Mar; 145(3):685-694. PubMed ID: 30603907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
